Affinivax
AcquiredCambridge, United States · $348.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Total Funding
- $348.5M
- Last Round
- $226.0M Series CJan 2021
- Rounds
- 4
About
Vaccine development platform leveraging technology from Boston Children's Hospital.
Summary
Affinivax is a Biotech company based in Cambridge, United States. It has raised $348.5M in total across 4 rounds, most recently a $226.0M Series C round in Jan 2021.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2022
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Google-backed biotechnology company focused on understanding the biology of aging to develop inte...